Europace Advance Access originally published online on August 14, 2008
Europace 2008 10(10):1145-1151; doi:10.1093/europace/eun203
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Implantable cardioverter-defibrillators
Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up
1 Division of Cardiology, Department of Internal Medicine, University of Oulu, PO Box 5000, 90014 Oulu, Finland; 2 Medtronic Bakken Research Center B.V., Maastricht, The Netherlands
Aims: The purpose of this prospective study was to investigate whether internet-based remote monitoring offers a safe, practical, and cost-effective alternative to the in-office follow-up visits of patients with an implantable cardioverter defibrillator (ICD).
Methods and results: Forty-one patients (62 ± 10 years, range 41–76, 83% male) with previously implanted ICD were followed for 9 months. One-hundred and nineteen scheduled and 18 unscheduled data transmissions were performed. There were no device-related adverse events. Over 90% of the patients found the system easy to use. Physicians reported the system as being very easy or easy to use and found the data comparable to traditional device interrogation in 99% of the cases. They were able to address all unscheduled data transmissions remotely. Compared with the in-office visits, remote monitoring required less time from patients (6.9 ± 5.0 vs. 182 ± 148 min, P < 0.001) and physicians (8.4 ± 4.5 vs. 25.8 ± 17.0 min, P < 0.001) to complete the follow-up. Substitution of two routine in-office visits during the study by remote monitoring reduced the overall cost of routine ICD follow-up by 524
per patient (41%).
Conclusion: Remote monitoring offers a safe, feasible, time-saving, and cost-effective solution to ICD follow-up.
Key Words: Implantable cardioverter defibrillator, Remote monitoring, Usability, Cost-effectiveness
* Corresponding author. Tel: +358 8 315 3550; fax: +358 8 315 2127. E-mail address: pekka.raatikainen{at}oulu.fi
Manuscript submitted 25 February 2008. Accepted after revision 15 July 2008.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Andrikopoulos, S. Tzeis, G. Theodorakis, and P. Vardas Monitoring capabilities of cardiac rhythm management devices Europace, October 29, 2009; (2009) eup317v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Burri and D. Senouf Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators Europace, June 1, 2009; 11(6): 701 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sacher, V. Probst, M. Bessouet, M. Wright, A. Maluski, S. Abbey, P. Bordachar, A. Deplagne, S. Ploux, G. Lande, et al. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population Europace, April 1, 2009; 11(4): 489 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Marine Remote monitoring for prevention of inappropriate implantable cardioverter defibrillator shocks: is there no place like home? Europace, April 1, 2009; 11(4): 409 - 411. [Full Text] [PDF] |
||||
